Yong Cheng Selected Research

1,2,4-trimethoxybenzene

2/2022	Correction: 1,2,4-Trimethoxybenzene selectively inhibits NLRP3 inflammasome activation and attenuates experimental autoimmune encephalomyelitis.
11/2021	1,2,4-Trimethoxybenzene selectively inhibits NLRP3 inflammasome activation and attenuates experimental autoimmune encephalomyelitis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yong Cheng Research Topics

Disease

36	Neoplasms (Cancer) 06/2022 - 01/2002
15	Schizophrenia (Dementia Praecox) 01/2022 - 11/2018
15	Alzheimer Disease (Alzheimer's Disease) 01/2022 - 09/2004
10	Inflammation (Inflammations) 01/2022 - 11/2016
9	Parkinson Disease (Parkinson's Disease) 01/2022 - 01/2016
9	Retinopathy of Prematurity (Retrolental Fibroplasia) 01/2022 - 07/2018
8	Infections 10/2020 - 04/2006
7	Hypoxia (Hypoxemia) 01/2021 - 07/2005
6	Neoplasm Metastasis (Metastasis) 06/2022 - 08/2012
6	Tuberculosis (Tuberculoses) 08/2020 - 08/2010
5	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2022 - 09/2006
5	Colorectal Neoplasms (Colorectal Cancer) 01/2022 - 01/2013
5	Hemorrhage 01/2022 - 06/2013
4	Squamous Cell Carcinoma of Head and Neck 06/2022 - 08/2015
4	Wounds and Injuries (Trauma) 05/2022 - 11/2011
4	Autism Spectrum Disorder 01/2022 - 11/2016
4	Memory Disorders (Memory Loss) 01/2022 - 09/2004
4	Major Depressive Disorder (Major Depressive Disorders) 01/2022 - 01/2020
4	Atherosclerosis 12/2021 - 12/2011
4	Sialadenitis 11/2021 - 12/2018
4	Pain (Aches) 01/2021 - 08/2014
4	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2021 - 01/2016
4	Retinoblastoma (Glioblastoma, Retinal) 12/2017 - 02/2015
3	Body Weight (Weight, Body) 05/2022 - 04/2010
3	Bites and Stings (Sting) 01/2022 - 10/2017
3	Ischemia 01/2022 - 02/2005
3	Dementia (Dementias) 01/2022 - 10/2004
3	Conversion Disorder (Astasia Abasia) 06/2021 - 07/2020
3	Carcinoma (Carcinomatosis) 01/2021 - 01/2002
3	Stomach Neoplasms (Stomach Cancer) 08/2019 - 07/2014
3	Polypoidal Choroidal Vasculopathy 11/2016 - 01/2014
3	Temporomandibular Joint Disorders (Temporomandibular Joint Disorder) 10/2010 - 07/2005
2	Carcinogenesis 06/2022 - 04/2019
2	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 02/2022 - 11/2021
2	Myopia 01/2022 - 01/2020
2	Neuroinflammatory Diseases 01/2022 - 01/2019
2	Autistic Disorder (Autism) 01/2022 - 11/2016
2	Multiple Sclerosis 11/2021 - 01/2019
2	Stroke (Strokes) 11/2021 - 01/2013
2	Melanoma (Melanoma, Malignant) 11/2021 - 03/2009
2	Anemia 10/2021 - 01/2021
2	COVID-19 09/2021 - 01/2021
2	Glioma (Gliomas) 06/2021 - 01/2021

Drug/Important Bio-Agent (IBA)

17	CytokinesIBA 01/2022 - 11/2016
14	Biomarkers (Surrogate Marker)IBA 01/2022 - 04/2012
14	Pharmaceutical PreparationsIBA 01/2022 - 02/2005
14	Proteins (Proteins, Gene)FDA Link 10/2020 - 02/2006
13	MicroRNAs (MicroRNA)IBA 06/2022 - 11/2012
11	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2022 - 03/2009
9	Messenger RNA (mRNA)IBA 06/2022 - 01/2002
7	KH902 fusion proteinIBA 01/2022 - 05/2016
6	AntioxidantsIBA 05/2022 - 01/2006
6	EnzymesIBA 01/2022 - 07/2005
5	Biological ProductsIBA 01/2022 - 07/2005
5	Brain-Derived Neurotrophic Factor (BDNF)IBA 01/2022 - 11/2016
5	Interleukin-6 (Interleukin 6)IBA 01/2022 - 08/2013
5	Antipsychotic Agents (Antipsychotics)IBA 01/2022 - 11/2018
5	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 10/2012
5	Retinaldehyde (Retinal)IBA 01/2019 - 11/2016
4	Neuroprotective AgentsIBA 07/2021 - 10/2004
4	Long Noncoding RNAIBA 01/2021 - 01/2016
4	Ranibizumab (Lucentis)FDA Link 12/2020 - 01/2019
4	Peptides (Polypeptides)IBA 11/2020 - 10/2015
4	Telomerase (Telomerase Reverse Transcriptase)IBA 01/2019 - 04/2015
3	InflammasomesIBA 02/2022 - 11/2021
3	LipopolysaccharidesIBA 01/2022 - 01/2019
3	CholesterolIBA 12/2021 - 10/2018
3	ApolipoproteinsIBA 12/2021 - 10/2018
3	GlobinsIBA 01/2021 - 01/2021
3	Fetal Hemoglobin (Hemoglobin F)IBA 01/2021 - 01/2021
3	C-Reactive ProteinIBA 12/2020 - 09/2011
3	Amyloid beta-PeptidesIBA 08/2020 - 08/2010
3	Anti-Bacterial Agents (Antibiotics)IBA 01/2020 - 01/2014
3	Saline SolutionIBA 01/2020 - 08/2011
3	AntigensIBA 01/2017 - 12/2013
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 11/2016 - 09/2011
3	MelatoninIBA 02/2006 - 09/2004
2	Circular RNAIBA 06/2022 - 01/2021
2	1,2,4-trimethoxybenzeneIBA 02/2022 - 11/2021
2	1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA 01/2022 - 07/2021
2	Anesthetics (Anesthetic Agents)IBA 01/2022 - 01/2017
2	Nucleic AcidsIBA 01/2022 - 03/2017
2	Interleukin-8 (Interleukin 8)IBA 01/2022 - 12/2020
2	Fibroblast Growth Factors (Fibroblast Growth Factor)IBA 01/2022 - 09/2019
2	LipidsIBA 12/2021 - 03/2019
2	Histone Deacetylase InhibitorsIBA 10/2021 - 12/2016
2	AerosolsIBA 09/2021 - 12/2013

Therapy/Procedure

18	Therapeutics 01/2022 - 06/2013
5	Neoadjuvant Therapy 01/2020 - 12/2013
4	Intravitreal Injections 01/2022 - 05/2016
3	Lasers (Laser) 01/2022 - 10/2013
3	Radiotherapy 01/2021 - 02/2014
3	Ligation 01/2020 - 10/2015
3	Hysterectomy 02/2018 - 08/2012
3	Drug Therapy (Chemotherapy) 10/2016 - 10/2012
2	Light Coagulation 01/2022 - 01/2022
2	Laser Therapy (Surgery, Laser) 01/2022 - 01/2022
2	Catheters 01/2022 - 02/2018
2	Length of Stay 01/2022 - 03/2015
2	Electrodes (Electrode) 06/2021 - 07/2020